OnKure Therapeutics (OKUR) Net Shares Issued and Repurchased (2021 - 2026)

OnKure Therapeutics (OKUR) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $29300.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 95.9% year-over-year to $29300.0; the trailing twelve-month figure through Mar 2026 stood at $29300.0 (down 95.9% YoY), and the FY2025 full-year result was $774800.0, down 56.36% from the prior year.
• Net Shares Issued and Repurchased slipped to $29300.0 in Q1 2026 per OKUR's latest filing, from $774800.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.1 million in Q4 2022 and bottomed at $29300.0 in Q1 2026.
• Historically, Net Shares Issued and Repurchased has averaged $801637.3 across 5 years, with a median of $714100.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Net Shares Issued and Repurchased jumped 270.55% in 2024, then plunged 95.9% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.1 million in 2022, then tumbled by 52.53% to $981582.0 in 2023, then surged by 80.86% to $1.8 million in 2024, then sank by 56.36% to $774800.0 in 2025, then plunged by 96.22% to $29300.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $29300.0, $774800.0, and $714100.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.